These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3076034)

  • 1. [Neoplasms, enzymes and enzymatic markers].
    Rokicki M; Rokicki W; Stanosek J
    Wiad Lek; 1988 Sep; 41(18):1218-23. PubMed ID: 3076034
    [No Abstract]   [Full Text] [Related]  

  • 2. [Possibilities and limits of enzymatic tumour diagnosis. II. Communication: Enzymes as general tumour markers (author's transl)].
    Hempel RD; Müller G; Rose H; Riessbeck KH; Haschen RJ; Burchardt U; Hempel A
    Radiobiol Radiother (Berl); 1981; 22(5):588-92. PubMed ID: 7339680
    [No Abstract]   [Full Text] [Related]  

  • 3. [Enzymes and isoenzymes as tumor markers].
    Ziegenbein R
    Radiobiol Radiother (Berl); 1983; 24(4):521-4. PubMed ID: 6647798
    [No Abstract]   [Full Text] [Related]  

  • 4. [Multivariate discriminant analysis--a current method for evaluating the enzyme spectrum in cancer patients].
    Klöppel R; Kamprad F; Winiecki P
    Vopr Onkol; 1985; 31(11):11-3. PubMed ID: 4072077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum alkaline deoxyribonuclease activity, a sensitive marker for the therapeutic monitoring of cancer patients: methodological aspects.
    Dewez B; Lans M; Allaeys V; Karaoglou A; Taper H; Roberfroid M
    Eur J Clin Chem Clin Biochem; 1993 Nov; 31(11):793-7. PubMed ID: 8305624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enzyme diagnosis and therapy in surgery].
    Gürtner T
    Med Monatsschr; 1967 Nov; 21(11):489-94. PubMed ID: 5306165
    [No Abstract]   [Full Text] [Related]  

  • 7. [Status and development of enzymatic diagnosis (review of the literature)].
    Danev S
    Lab Delo; 1973; 4():199-207. PubMed ID: 4125467
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biological markers of hepatocellular carcinoma].
    Arfaoui D; Elloumi H; Ajmi S
    Tunis Med; 2004 Apr; 82(4):329-34. PubMed ID: 15453027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma sialyltransferase as a tumor marker.
    Dwivedi C; Dixit M; Hardy RE
    Cancer Detect Prev; 1988; 11(3-6):191-6. PubMed ID: 3390843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of serum markers in diagnosis and treatment monitoring in patients with lung cancer].
    Jassem E; Jassem J
    Przegl Lek; 1995; 52(8):392-4. PubMed ID: 8525011
    [No Abstract]   [Full Text] [Related]  

  • 11. Review of circulating tumor markers: from enzyme, carcinoembryonic protein to oncogene and suppressor gene.
    Wu JT
    Ann Clin Lab Sci; 1999; 29(2):106-11. PubMed ID: 10219697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities and limits of enzymatic tumour diagnosis. I. Communication: Organ-dependent diagnosis (author's transl)].
    Hempel RD; Müller G; Rose H; Riessbeck KH; Haschen RJ; Burchardt U; Hempel A; Redlow H
    Radiobiol Radiother (Berl); 1981; 22(5):581-7. PubMed ID: 7339679
    [No Abstract]   [Full Text] [Related]  

  • 13. Ribonucleases and deoxyribonucleases in pancreatic cancer: clinical value and pathophysiological interrelationships.
    Del Favero G; Basso D; Fabris C; Angonese C; Meani A; Vianello D; Pedrazzoli S; Dodi G; Naccarato R
    Int J Pancreatol; 1988; 3 Suppl 1():S107-12. PubMed ID: 3209863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enzymatic diagnosis of malignant tumors].
    Tsubura E; Masaki S; Kameo T; Yamamura Y
    Rinsho Byori; 1970 Mar; 18(3):156-62. PubMed ID: 5462823
    [No Abstract]   [Full Text] [Related]  

  • 15. A new method for detecting beta 1,4-galactosyltransferase activity in sera of cancer patients.
    Taki T; Nishiwaki S; Handa N; Hattori N; Handa S
    Anal Biochem; 1994 May; 219(1):104-8. PubMed ID: 8059935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Good clinical use of serum tumor markers].
    Boussen H; el May M; Jerbi G; Rahal K; Benna F; Mtimet S; Ben Ayed F
    Tunis Med; 1998 Feb; 76(2):1020-6. PubMed ID: 9844536
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tumor markers--serologic parameters for monitoring and therapeutic control of cancer patients].
    Birkmayer J
    Wien Med Wochenschr; 1988 Jun; 138(11-12):276-8. PubMed ID: 3176507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Further study of tumor markers].
    Li C
    Zhonghua Yi Xue Za Zhi; 1993 Aug; 73(8):451-2. PubMed ID: 7509251
    [No Abstract]   [Full Text] [Related]  

  • 19. [Criteria for using tumor markers. 2: Indications and interpretation].
    Fateh-Moghadam VA; Stieber P
    Fortschr Med; 1996 Mar; 114(7):38-40. PubMed ID: 8900968
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance and task requirements of enzymatic diagnosis in radiotherapy of tumor diseases].
    Riessbeck KH; Neumeister K; Hempel RD; Rose H
    Radiobiol Radiother (Berl); 1983; 24(4):531-7. PubMed ID: 6647800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.